Literature DB >> 18678165

[Effect of acupuncture on target action of ligustrazine in treatment of toxic deafness induced by gentamicin in guinea pigs].

Hua-Ping Zheng1, Feng Wang, Quan-Zhen Xu, Fei Xu, Guo-Jun Zhang, Peng Wang, Yong-Hua Wang, Jin-Hong Liu, Bing-hua Fan.   

Abstract

OBJECTIVE: To explore an effective method for treating Gentamicin-induced deafness and the mechanism.
METHODS: Guinea pigs were randomly divided into 5 groups: normal control group (group A), model group (group B), Ligustrazine group (group C), acupuncture group (group D) and Ligustrazine plus acupuncture group (group E). The group C, D and E were treated respectively by simple Ligustrazine, simple acupuncture at "Tinggong" (SI 19), "Yifeng" (TE 17), and "Waiguan" (TE 5), and Ligustrazine plus acupuncture. Ten days later, the auditory brainstem response (ABR) thresholds for the wave III , apoptosis and expressions of Bcl-2 and Bax proteins in the organ of Corti of the guinea pig were detected.
RESULTS: In the group E, the ABR threshold was significantly lower than that in the group C (P<0.05), and apoptotic cells, the expression of Bax protein and the ratio of Bax/Bcl-2 were lower than those in the group C and D in the organ of Corti, and Bcl-2 protein expression was increased.
CONCLUSION: Acupuncture at "Tinggong" (SI 19), "Yifeng" (TE 17), and "Waiguan" (TE 5) has a certain target-synergistic action on Ligustrazine and can increase therapeutic effect of Ligustrazine on Gentamicin-induced deafness, which are possible related with the inhibition of apoptosis, down-regulation of Bax expression and up-regulation of Bcl-2 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678165

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  1 in total

1.  Protective Effects of Acupuncture Against Gentamicin-Induced Ototoxicity in Rats: Possible Role of Neurotrophin-3.

Authors:  Ping Zhou; Weijun Ma; Ying Sheng; Maoli Duan; Xiaotong Zhang
Journal:  Med Sci Monit       Date:  2017-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.